Isabelle de Cremoux is the CEO and Managing Partner of Seventure Partners. See sector focus and contact routes.
Isabelle de Cremoux is the CEO and Managing Partner of Seventure Partners, a Paris-based venture capital firm where she leads the Life Sciences team and has served as CEO since 2014. She joined the firm in 2001 to establish its Life Sciences division and personally invests in biotech, nutrition, healthcare, and personalized medicine across France, Scandinavia, and North America. Her investment thesis targets Series A and B stages with a focus on sectors beyond traditional pharmaceuticals, notably pioneering the world’s first microbiome-focused venture fund, Health for Life Capital. Seventure typically invests between $685,000 and $27 million per deal, with de Cremoux often taking a lead role in key biotech transactions. Notable portfolio companies she has supervised or invested in include Enterome Biosciences, Maat Pharma, Targedys, and the listed company ArgenX. De Cremoux is recognized for her distinctive focus on “beyond the pill” investments in the microbiome and nutrition space, positioning Seventure as a leader in this emerging therapeutic area.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Paris.
Investors like Isabelle de Cremoux · Full investor directory · Investor access · Company funding database